PA
THG icon

PharVision Advisers’s Hanover Insurance THG Stock Holding History

PharVision Advisers’s Portfolio THG Stock Details THG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,978
Closed -$362K – 594
2025
Q4 		$362K Buy
+1,978
New +$356K 0.18% 163
2025
Q3 		– Sell
-1,391
Closed -$236K – 795
2025
Q2 		$236K Buy
+1,391
New +$232K 0.34% 154

Other funds holding THG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PharVision Advisers's THG Position: Q1 2026 in Review

PharVision Advisers sold out of Hanover Insurance (THG) in Q1 2026, closing a stake of 1,978 shares — an estimated $362K sold.

PharVision Advisers first reported a position in THG in Q2 2025 and held it in 2 quarters. The position peaked at $362K in Q4 2025. 503 funds tracked by Wall St. Rank hold THG as of Q1 2026.

  • PharVision Advisers reported no remaining Hanover Insurance position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 1,978 Hanover Insurance shares in Q1 2026, an estimated $362K.
  • PharVision Advisers first reported a position in Hanover Insurance in Q2 2025 and held it in 2 quarters.
  • PharVision Advisers's Hanover Insurance position peaked at $362K in Q4 2025.
  • 503 funds tracked by Wall St. Rank held Hanover Insurance as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.